Aggregated Pattern Classification Method for improving neural disorder stage detection

Abstract

BackgroundNeurological disorders pose a significant health challenge, and their early detection is critical for effective treatment planning and prognosis. Traditional classification of neural disorders based on causes, symptoms, developmental stage, severity, and nervous system effects has limitations. Leveraging artificial intelligence (AI) and machine learning (ML) for pattern recognition provides a potent solution to address these challenges. Therefore, this study focuses on proposing an innovative approach—the Aggregated Pattern Classification Method (APCM)—for precise identification of neural disorder stages.MethodThe APCM was introduced to address prevalent issues in neural disorder detection, such as overfitting, robustness, and interoperability. This method utilizes aggregative patterns and classification learning functions to mitigate these challenges and enhance overall recognition accuracy, even in imbalanced data. The analysis involves neural images using observations from healthy individuals as a reference. Action response patterns from diverse inputs are mapped to identify similar features, establishing the disorder ratio. The stages are correlated based on available responses and associated neural data, with a preference for classification learning. This classification necessitates image and labeled data to prevent additional flaws in pattern recognition. Recognition and classification occur through multiple iterations, incorporating similar and diverse neural features. The learning process is finely tuned for minute classifications using labeled and unlabeled input data.ResultsThe proposed APCM demonstrates notable achievements, with high pattern recognition (15.03%) and controlled classification errors (CEs) (10.61% less). The method effectively addresses overfitting, robustness, and interoperability issues, showcasing its potential as a powerful tool for detecting neural disorders at different stages. The ability to handle imbalanced data contributes to the overall success of the algorithm.ConclusionThe APCM emerges as a promising and effective approach for identifying precise neural disorder stages. By leveraging AI and ML, the method successfully resolves key challenges in pattern recognition. The high pattern recognition and reduced CEs underscore the method's potential for clinical applications. However, it is essential to acknowledge the reliance on high‐quality neural image data, which may limit the generalizability of the approach. The proposed method allows future research to refine further and enhance its interpretability, providing valuable insights into neural disorder progression and underlying biological mechanisms.